Diagnos (TSE:ADK)
:ADK
ADK Stock Chart & Stats
C$0.36
C$0.03(9.38%)
At close: 4:00 PM EST
C$0.36
C$0.03(9.38%)
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.42
Previous CloseN/A
Volume270.50K
Average Volume (3M)342.67K
Market Cap
C$33.11M
Enterprise ValueC$29.62M
Total Cash (Recent Filing)C$3.40M
Total Debt (Recent Filing)C$2.00M
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Jun 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding120,412,550
10 Day Avg. Volume531,548
30 Day Avg. Volume342,665
Financial Highlights & Ratios
PEG Ratio-0.45
Price to Book (P/B)-6.56
Price to Sales (P/S)117.69
P/FCF Ratio-9.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Equity PositionRecent movement to positive equity provides a cleaner balance sheet base and reduces immediate insolvency risk. That repair increases capacity to absorb losses, improves lender/investor confidence, and creates a modest cushion that supports survival and strategic options over the next 2–6 months.
Lean Operating FootprintA small headcount suggests a low fixed-cost operating model that can scale with limited incremental payroll burden. This structural lean footprint helps conserve cash, makes cost reductions easier if needed, and supports operational flexibility during a multi-quarter turnaround.
Industry Exposure To Healthcare ITBeing in healthcare information services places the company in a sector with durable secular demand for digitization and data services. Structural industry tailwinds can sustain long-term revenue opportunities and partnerships, aiding recovery if product-market fit and execution improve.
Bears Say
Persistent Cash BurnConsistent negative operating and free cash flow indicates ongoing cash consumption that will require financing or dilution. Persistent burn constrains investment in product and sales, increases refinancing risk within months, and limits the company’s ability to execute strategic initiatives.
Declining Revenue And Weak MarginsFalling revenue combined with negative gross profit, EBITDA and net income shows the business lacks near-term scaling and margin leverage. Without revenue stabilization or structural margin improvement, profitability remains distant and cash needs will likely persist over multiple quarters.
High Leverage And Balance-sheet InstabilityMaterial debt vs a small, volatile equity base increases refinancing and covenant risk. High leverage amplifies the impact of continued losses, can raise funding costs, and limits flexibility to invest or restructure, making capital access and solvency conditional on near-term funding events.
Diagnos News
ADK FAQ
What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.18 and its highest was C$0.41 in the past 12 months.
What is Diagnos’s market cap?
Diagnos’s market cap is C$33.11M.
When is Diagnos’s upcoming earnings report date?
Diagnos’s upcoming earnings report date is Jun 04, 2026 which is in 59 days.
How were Diagnos’s earnings last quarter?
Diagnos released its earnings results on Feb 25, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Diagnos overvalued?
According to Wall Street analysts Diagnos’s price is currently Overvalued.
Does Diagnos pay dividends?
Diagnos does not currently pay dividends.
What is Diagnos’s EPS estimate?
Diagnos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos have?
Diagnos has 120,412,550 shares outstanding.
What happened to Diagnos’s price movement after its last earnings report?
Diagnos reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.754%.
Which hedge fund is a major shareholder of Diagnos?
Currently, no hedge funds are holding shares in TSE:ADK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Diagnos Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$95.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.46%
12-Months-Change
Fundamentals
Return on Equity
3086.87%
Trailing 12-Months
Asset Growth
22.12%
Trailing 12-Months
Company Description
Diagnos
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Technical Analysis
Rocket Doctor AI
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―
PanGenomic Health, Inc. Class A
―
DiagnaMed Holdings Corp.
―
Options Prices
Currently, No data available
---